[1] |
Bankamp B, Hickman C, Icenogle JP, et al. Successes and challenges for preventing measles, mumps and rubella by vaccination. Curr Opin Virol, 2019; 34, 110−6. doi: 10.1016/j.coviro.2019.01.002 |
[2] |
Pan JH, Wang YS, Cao LS, et al. Impact of immunization programs on 11 childhood vaccine-preventable diseases in China: 1950-2018. Innovation (Camb), 2021; 2, 100113. |
[3] |
World Health Organization. “Global measles and rubella strategic plan: 2021-2030” in Tech. Report No. ISBN 978-92-4-001561-6 (electronic version), (World Health Organization, Geneva, Switzerland, 2020). |
[4] |
World Health Organization. Measles reported cases and incidence. https://immunizationdata.who.int/pages/incidence/MEASLES.html?CODE=Global&YEAR=. [2023-10-17]. |
[5] |
Guerra FM, Bolotin S, Lim G, et al. The basic reproduction number (R0) of measles: a systematic review. Lancet Infect Dis, 2017; 17, e420−e428. doi: 10.1016/S1473-3099(17)30307-9 |
[6] |
World Health Organization. Rubella reported cases and incidence. https://immunizationdata.who.int/pages/incidence/RUBELLA.html?CODE=Global&YEAR=. [2023-10-17] |
[7] |
Winter AK, Moss WJ. Rubella. Lancet, 2022; 399, 1336−46. doi: 10.1016/S0140-6736(21)02691-X |
[8] |
Hviid A, Rubin S, Mühlemann K. Mumps. Lancet, 2008; 371, 932−44. doi: 10.1016/S0140-6736(08)60419-5 |
[9] |
Su SB, Chang HL, Chen AKT. Current status of mumps virus infection: epidemiology, pathogenesis, and vaccine. Int J Environ Res Public Health, 2020; 17, 1686. doi: 10.3390/ijerph17051686 |
[10] |
Centers for Disease Control and Prevention. Measles Cases and Outbreaks. https://www.cdc.gov/measles/data-research/index.html. [2024-11-17]. |
[11] |
Majumder MS, Cohn EL, Mekaru SR, et al. Substandard vaccination compliance and the 2015 measles outbreak. JAMA Pediatr, 2015; 169, 494−5. doi: 10.1001/jamapediatrics.2015.0384 |
[12] |
Truelove SA, Graham M, Moss WJ, et al. Characterizing the impact of spatial clustering of susceptibility for measles elimination. Vaccine, 2019; 37, 732−41. doi: 10.1016/j.vaccine.2018.12.012 |
[13] |
Song QW, Ma C, Hao LX, et al. Healthy China: effects of Three Major Immunization Interventions on Measles Control - China, 1952-2021. China CDC Wkly, 2023; 5, 385−90. doi: 10.46234/ccdcw2023.073 |
[14] |
Fu XF, Ge MJ, Xu WC, et al. Epidemiological features and sociodemographic factors associated with mumps in mainland of China from 2004 to 2018. J Med Virol, 2022; 94, 4850−9. doi: 10.1002/jmv.27955 |
[15] |
Su QR, Ma C, Wen N, et al. Epidemiological profile and progress toward rubella elimination in China. 10 years after nationwide introduction of rubella vaccine. Vaccine, 2018; 36, 2079−85. doi: 10.1016/j.vaccine.2018.03.013 |
[16] |
Ma YX, Zhou JD, Yang SX, et al. Assessment for the impact of dust events on measles incidence in western China. Atmos Environ, 2017; 157, 1−9. doi: 10.1016/j.atmosenv.2017.03.010 |
[17] |
Chinese Center for Disease Control and Prevention. National Measles Surveillance Programme. https://www.chinacdc.cn/jkzt/crb/zl/mz/jszl_2205/200904/t20090413_24216.html. (In Chinese). [2023-10-17]. |
[18] |
Chinese Center for Disease Control and Prevention. Diagnostic Criteria for Mumps (WS270-2007). https://icdc.chinacdc.cn/zcfgybz/bz/202112/t20211202_253350.html. (In Chinese). [2023-10-17]. |
[19] |
Chinese Center for Disease Control and Prevention. Diagnostic Criteria for Rubella (WS297-2008). https://icdc.chinacdc.cn/zcfgybz/bz/202112/t20211202_253326.html. (In Chinese) |
[20] |
Zheng JY, Zhang N, Shen GQ, et al. Spatiotemporal and seasonal trends of class A and B notifiable infectious diseases in China: retrospective analysis. JMIR Public Health Surveill, 2023; 9, e42820. doi: 10.2196/42820 |
[21] |
Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med, 2000; 19, 335−51. doi: 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z |
[22] |
Lee S, Moon J, Jung I. Optimizing the maximum reported cluster size in the spatial scan statistic for survival data. Int J Health Geogr, 2021; 20, 33. doi: 10.1186/s12942-021-00286-w |
[23] |
Yiannakoulias N. Using population attributable risk to understand geographic disease clusters. Health Place, 2009; 15, 1142−8. doi: 10.1016/j.healthplace.2009.07.001 |
[24] |
Anselin L, Syabri I, Kho Y. GeoDa: An introduction to spatial data analysis. Geogr Anal, 2006; 38, 5−22. doi: 10.1111/j.0016-7363.2005.00671.x |
[25] |
Anselin L, Sridharan S, Gholston S. Using exploratory spatial data analysis to leverage social indicator databases: the discovery of interesting patterns. Soc Indic Res, 2007; 82, 287−309. doi: 10.1007/s11205-006-9034-x |
[26] |
Dixon MG, Ferrari M, Antoni S, et al. Progress toward regional measles elimination - worldwide, 2000-2020. Morb Mortal Wkly Rep, 2021; 70, 1563−9. doi: 10.15585/mmwr.mm7045a1 |
[27] |
Kim S, Headley TY, Tozan Y. Universal healthcare coverage and health service delivery before and during the COVID-19 pandemic: a difference-in-difference study of childhood immunization coverage from 195 countries. PLoS Med, 2022; 19, e1004060. doi: 10.1371/journal.pmed.1004060 |
[28] |
Shet A, Carr K, Danovaro-Holliday MC, et al. Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories. Lancet Glob Health, 2022; 10, e186−94. doi: 10.1016/S2214-109X(21)00512-X |
[29] |
Ho LL, Gurung S, Mirza I, et al. Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns. Int J Infect Dis, 2022; 119, 201−9. doi: 10.1016/j.ijid.2022.04.005 |
[30] |
Marshall HS, Plotkin S. The changing epidemiology of mumps in a high vaccination era. Lancet Infect Dis, 2019; 19, 118−9. doi: 10.1016/S1473-3099(18)30541-3 |
[31] |
Westphal DW, Eastwood A, Levy A, et al. A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study. Lancet Infect Dis, 2019; 19, 177−84. doi: 10.1016/S1473-3099(18)30498-5 |
[32] |
Lewnard JA, Grad YH. Vaccine waning and mumps re-emergence in the United States. Sci Transl Med, 2018; 10, eaao5945. doi: 10.1126/scitranslmed.aao5945 |
[33] |
Connell AR, Connell J, Leahy TR, et al. Mumps outbreaks in vaccinated populations-is it time to re-assess the clinical efficacy of vaccines? Front Immunol, 2020; 11, 2089. |
[34] |
Barskey AE, Schulte C, Rosen JB, et al. Mumps outbreak in orthodox Jewish communities in the United States. N Engl J Med, 2012; 367, 1704−13. doi: 10.1056/NEJMoa1202865 |
[35] |
Smetana J, Chlibek R, Hanovcova I, et al. Serological survey of mumps antibodies in adults in the Czech Republic and the need for changes to the vaccination strategy. Hum Vaccin Immunother, 2018; 14, 887−93. doi: 10.1080/21645515.2017.1412021 |
[36] |
Braeye T, Linina I, De Roy R, et al. Mumps increase in Flanders, Belgium, 2012-2013: results from temporary mandatory notification and a cohort study among university students. Vaccine, 2014; 32, 4393−8. doi: 10.1016/j.vaccine.2014.06.069 |
[37] |
Deal A, Halliday R, Crawshaw AF, et al. Migration and outbreaks of vaccine-preventable disease in Europe: a systematic review. Lancet Infect Dis, 2021; 21, e387−98. doi: 10.1016/S1473-3099(21)00193-6 |
[38] |
Hiebert J, Saboui M, Frost J R, et al. Mumps resurgence in a highly vaccinated population: insights gained from surveillance in Canada, 2002-2020. Vaccine, 2023; 41, 3728−39. doi: 10.1016/j.vaccine.2023.04.078 |
[39] |
Principi N, Autore G, Ramundo G, et al. Epidemiology of respiratory infections during the COVID-19 pandemic. Viruses, 2023; 15, 1160. doi: 10.3390/v15051160 |
[40] |
Wang Y, Cui AL, Xu WB, et al. Analysis on the reported mumps public health emergencies and its influencing factors in China from 2004 to 2020. Chin J Exp Clin Virol, 2021; 35, 176. (In Chinese) |
[41] |
Javelle E, Colson P, Parola P, et al. Measles, the need for a paradigm shift. Eur J Epidemiol, 2019; 34, 897−915. doi: 10.1007/s10654-019-00569-4 |
[42] |
Beaty SM, Lee B. Constraints on the genetic and antigenic variability of measles virus. Viruses, 2016; 8, 109. doi: 10.3390/v8040109 |
[43] |
Won H, Kim AR, Yoo JS, et al. Cross-neutralization between vaccine and circulating wild-type mumps viruses in Korea. Vaccine, 2021; 39, 1870−6. doi: 10.1016/j.vaccine.2021.01.039 |
[44] |
Peng L, Zhao XG, Tao Y, et al. The effects of air pollution and meteorological factors on measles cases in Lanzhou, China. Environ Sci Pollut Res Int, 2020; 27, 13524−33. doi: 10.1007/s11356-020-07903-4 |